| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 17 May 2024 | 9 May 2024 |
| SYNCOM FORMULATIONS (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2024 inter alia to consider and approve Pursuant to Regulation 29(1) (a) of SEBI (LODR) Regulations 2015 read with SEBI (PIT) Regulations 2015 as amended from time to time we are pleased to inform that 1/2024-25 Meeting of the Board of Directors of the Company is scheduled to be held on Friday the 17th day of May 2024 at 4:00 P.M. at the Corporate Office situated at 207 Saket Nagar Near Saket Club Indore (M.P.) 452018 to consider and approve the following businesses along with other routine businesses: a) To consider and approve Standalone and Consolidated Audited Financial Results of the Company for the Quarter and year ended 31st March 2024; b) To take on record the Standalone and Consolidated Audit Report by Auditors for the Audited Financial Results of the Company for the Quarter and year ended 31st March 2024. c) To consider and approve other matter incidental thereto. Publication of Financial Results for year ended 31.03.2024 (As Per BSE Announcement Dated on 18.05.2024) | ||
| Board Meeting | 14 Feb 2024 | 6 Feb 2024 |
| SYNCOM FORMULATIONS (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve Pursuant to Regulation 29(1) (a) of SEBI (LODR) Regulations 2015 read with SEBI (PIT) Regulations 2015 as amended from time to time we are pleased to inform that 5/2023-24 Meeting of the Board of Directors of the Company is scheduled to be held on Wednesday the 14th day of February 2024 at 11:00 A.M. at the Corporate Office situated at 207 Saket Nagar Near Saket Club Indore (M.P.) 452018 submission of unaudited standalone and consolidated financials for the quarter ended 31.12.2023 (As per BSE Announcement Dated on 14/02/2024) | ||
| Board Meeting | 8 Nov 2023 | 27 Oct 2023 |
| SYNCOM FORMULATIONS (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve With Reference to Regulation 29(1)(a) of SEBI (LODR) Regulations 2015 read with SEBI (PIT) Regulations 2015 we are pleased to inform that 4/2023-24 Meeting of the Board of directors of the Company is scheduled to be held on Wednesday 8th November 2023 at 11:00 A.M. at the Corporate office of the Company situated at 207 Saket Nagar near Saket Club Indore (M.P.) 452018 to consider and approve the following businesses :1.Approval of the Standalone and Consolidated Un-audited Financial Results for the Quarter and half year ended on 30th September 2023.2.To take on record the Limited Review Report by the Statutory Auditors for Un-audited Financial Results for the Quarter half year ended on 30th September 2023.3.Approval of the Standalone and Consolidated Un-audited Statement of Assets and Liabilities for the half-year ended 30th September 2023.4.Approval of the Standalone and Consolidated Un-audited Statement of Cash Flow for the half-year ended 30th September 2023. Regulation 33(3)(d) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 - Submission of Standalone & Consolidated Un-Audited Financial Results along with Limited Review Report thereon for the Quarter and Half year ended on 30th September, 2023. (As Per BSE Announcement dated on 08.11.2023) | ||
| Board Meeting | 14 Aug 2023 | 3 Aug 2023 |
| SYNCOM FORMULATIONS (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 inter alia to consider and approve we are pleased to inform that 3/2023-24 Meeting of the Board of Directors of the Company is scheduled to be held on Monday the 14th day of August 2023 at 11:00 A.M. at the Corporate Office situated at 207 Saket Nagar Near Saket Club Indore (M.P.) 452018to consider and approve the following businesses along with other routine businesses: a) To consider and approve Standalone and consolidated Un-audited Financial Results of the Company for the Quarter ended 30th June 2023; b) To take on record the Standalone and consolidated Limited Review Report by Auditors for the Financial Results of the Company for the Quarter ended 30th June 2023; c) To consider and approve other matter incidental thereto. This has in reference to our letter No. SYNCOM/SE/2023-24 dated 3rd August,2023 for notice under Regulation 29(1)(a) of SEBI (LODR) Regulations,2015 read with Regulation 30 of SEBI (LODR) Regulations,2015 and Schedule III of the said Regulations, by which it was informed that meeting No. 3/2023-24 of the Board of directors of the Company is to be held on Monday,14thAugust, 2023 at11:00 A.M (As Per BSE Announcement Dated on 14.08.2023) Pursuant to Reg 30 we enclose the newspaper advertisement published on 15.08.2023 in Free Press journal English Edition and Marathi Vernacular Newspaper. (As Per BSE Announcement Dated on 15/08/2023) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
